Daxor Operating Income 2010-2011 | DXR

Daxor operating income from 2010 to 2011. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Daxor Annual Operating Income
(Millions of US $)
2011 $-6
2010 $-6
2009 $-5
Daxor Quarterly Operating Income
(Millions of US $)
2011-12-31 $-1
2011-09-30 $-1
2011-06-30 $-1
2011-03-31 $-2
2010-12-31 $-2
2010-09-30 $-1
2010-06-30 $-2
2010-03-31 $-1
2009-12-31 $-1
2009-09-30 $-1
2009-06-30 $-1
2009-03-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.053B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.011B 19.12
Encompass Health (EHC) United States $12.109B 24.19
DaVita (DVA) United States $9.527B 13.62
Elanco Animal Health (ELAN) United States $8.794B 19.67
Chemed (CHE) United States $6.482B 21.71
RadNet (RDNT) United States $5.099B 184.14
Option Care Health (OPCH) United States $4.575B 19.58
LifeStance Health (LFST) United States $2.104B 0.00
Addus HomeCare (ADUS) United States $2.102B 22.66
Astrana Health (ASTH) United States $1.678B 58.71
Aveanna Healthcare Holdings (AVAH) United States $1.471B 27.08
U.S Physical Therapy (USPH) United States $1.281B 32.04
Atai Life Sciences (ATAI) Germany $0.868B 0.00
Pennant (PNTG) United States $0.868B 30.62
MEDIROM Healthcare Technologies (MRM) Japan $0.054B 0.00
Psychemedics (PMD) United States $0.000B 0.00